Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.
about
The fitness costs of antibiotic resistance mutationsEvolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapyImpact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosisGenome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South AfricaFitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotypeSpontaneous emergence of multiple drug resistance in tuberculosis before and during therapyDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentPre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroComparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from RussiaElucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingMycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315The Role of Adherence and Retreatment in De Novo Emergence of MDR-TBVirulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpCWhole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analysesImpact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis.Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1.Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, ChinaMutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia.Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from SpainThe Influence of HIV on the Evolution of Mycobacterium tuberculosis.Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon.Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activitiesPhenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine.Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistanceRapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath testImpact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosisPopulation genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.Molecular epidemiology of tuberculosis: current insights.Draft Genome Sequence of Mycobacterium tuberculosis Strain E186hv of Beijing B0/W Lineage with Reduced Virulence.Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
P2860
Q26825334-94567EF7-97A8-49B4-A391-797053673C98Q27016579-30536077-3003-481A-BC07-997EA414B690Q28469011-086B5AE2-6315-4304-96AD-1A738B397A85Q28471774-C9D7649F-066D-4D94-BB07-B4087B7DD132Q28473702-4D314169-6D25-438D-88DA-51CE9F1ADAA2Q28477566-B31EBB73-4ADC-460A-9154-38181818CCEFQ28478602-E0DD5F23-7ADB-4DA0-8DA9-52A5D9879D45Q28478663-DA4231FE-51B5-4BA7-946E-09F786A0A5D4Q28486275-AE8C93E2-9DAE-4AF6-BF47-6A2640CDBFF7Q28536869-D73030C6-D7C6-4CC6-B4D6-898AFE489E61Q28548282-181C0629-5388-4227-8603-9AE44B38C5A2Q28550707-A15162FC-7782-4A48-A5D9-CA608D222110Q28554450-EAE63456-AAC1-497F-B20A-DDDB9582DF1FQ31156691-9367151A-CB03-4465-9C66-77EE832848DBQ33283728-9CA3C3D5-7888-444E-9A6E-41FD3D7A585DQ33410693-F62C9181-220D-49AB-BAFB-629FD9AAAB24Q33595994-27652198-25FB-4181-BFA8-6F847AB73080Q33645712-CE02190D-C38B-4025-B00E-9B1B031FE3B2Q33676299-36DF8FA7-0BB3-4205-9CFD-88DC88F556E7Q33678559-F3333F1D-4DB5-4EED-B1BE-AEBD6142DE82Q33703858-A86862E0-5AE5-4345-84A5-A892FA03CF1EQ33752939-E41D1D49-B6FA-4CE9-8A6A-34848BB8CA64Q33757201-4B2BFD2C-EB4B-4AB5-9BAA-A411CE078E2FQ33826352-1A3C8D79-0751-47BC-A28F-02111E788E27Q33832822-C0A96279-AD48-401F-B3F1-EEF1C97356C8Q33836289-F6AAF8A3-B95C-4FBC-B8D5-890F6A1F9F21Q33836636-63763321-7447-4DC1-89F4-200D5C7A80A3Q33856525-0E05EDA3-8540-4F99-AA3A-9481AA4A0277Q33858360-13B30C27-6F97-4B36-83AC-635051A7DD36Q33935393-AA2BEE73-DA4C-4126-9D3A-5213D1A0A6B6Q34278222-85E495B3-4B62-4017-87BA-3541530035C9Q34287653-52D7CCC9-14D1-430A-9AA1-8855FD4D7955Q34973711-D6C63942-B0F4-4FDB-A7EA-17E6770CC152Q34974987-1D2AAACF-B4B9-434A-B7DC-77B9D2845A36Q35065085-16C5F803-D227-4F18-A0B4-AD84BB5D3EF0Q35070843-88B00A34-DA56-4821-8F16-CFA95CC34F18Q35582974-AC1907E1-FA8D-4977-B20A-46CF68DE898CQ35768714-37FED7E1-5089-4B13-A254-C982B4AC5F5EQ35806549-31C16A38-E07A-4D26-9853-32D1236CF152Q35909558-C6872520-AC91-4ED8-BE27-3C019BCDDE9A
P2860
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of katG mutations on th ...... on for transmission in humans.
@ast
Effect of katG mutations on th ...... on for transmission in humans.
@en
Effect of katG mutations on th ...... on for transmission in humans.
@nl
type
label
Effect of katG mutations on th ...... on for transmission in humans.
@ast
Effect of katG mutations on th ...... on for transmission in humans.
@en
Effect of katG mutations on th ...... on for transmission in humans.
@nl
prefLabel
Effect of katG mutations on th ...... on for transmission in humans.
@ast
Effect of katG mutations on th ...... on for transmission in humans.
@en
Effect of katG mutations on th ...... on for transmission in humans.
@nl
P2860
P1476
Effect of katG mutations on th ...... ion for transmission in humans
@en
P2093
Brigitte Saint-Joanis
Stewart T Cole
P2860
P304
P356
10.1128/IAI.70.9.4955-4960.2002
P407
P577
2002-09-01T00:00:00Z